Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group
We Recommend
Disclosures
Nothing to disclose
Advertisement
Sign In
New at TCTMD? Register today!
Forgot Your Password?
Enter the email you used to register to reset your password.
Search TCTMD
cme